COVID-19

Covid image Sarah Griffin

Impact of COVID-19 on Medical Device Sales and Reimbursement in Australia

By Sarah Griffin | 10 August 2020
Our reimbursement adviser, Sarah Griffin talks about the impact COVID-19 has had on Sales and Reimbursement in the Australian Medical Device industry. Australia has been very fortunate in that it...
shutterstock_572893948

What you need to know about disinfectants in Australia

By Jenny Lin | 7 August 2020
In May 2020, we looked at hand sanitisers and TGA’s exemption on certain formations in response to the COVID-19 emergency. As we are seeing an increasing number of corporations receiving...
Picture 1

EC Acts Quickly – and issues proposal to delay MDR deadline amidst COVID Pandemic

By Luis Jimenez | 2 April 2020
With sweeping speed, the European Commission (EC) has issued its proposal to postpone the deadline of the transition from MDD to MDR. The goal is to have the European Parliament...

Search

Recent Posts

Gas Pathways – ISO 18562 progress

Aug 20, 2021

When is a Standard Actually a Standard?

Jul 26, 2021

The bio pharmacy: market authorisations for protein-based medicines

Jul 12, 2021

Update on Notified Bodies designation under MDR / IVDR

Jul 2, 2021

MR Compatibility and Materials Science

Jul 1, 2021

Australia’s TGA releases updated Essential Principles Checklist

May 27, 2021

Categories

Categories

Archives

Archives

Archives

Tags

510(k) ARTG Australia Biocompatibility Brexit CE China clinical evidence clinical trials Conformity Assessment coronavirus COVID-19 COVID19 Drug EU Europe FDA guidance IVD IVDD IVDR IVDs MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines MHRA NMPA Notified Bodies Pharmaceutical PMA postmarket Reform Registrations regulatory Reimbursement SaMD Software Software as a Medical Device (SaMD) standards TGA